Former Janssen Medical Affairs VP Li Bin Joins Roche as Vice President of Medical and Personalized Healthcare for China
Jun 24, 2021 10:19
CST Updated
10:19
Roche
Oncology Drug Research, Development, and Manufacturing
Roche Pharma China
Pharmaceutical Manufacturer
Xian Janssen
Pharmaceutical R&D and Manufacturer
On June 23, Roche Pharma announced that Li Bin will be appointed as Vice President, Medical and Personalized Healthcare, Roche Pharma China, joining the Roche Pharma China management team and reporting directly to Zhou Hong, President of Roche Pharma China, effective July 12, 2021.
It is reported that prior to joining Roche, Li Bin served as Vice President of Medical Affairs at Xian Janssen.
*Disclaimer: This article was written by a contributing author to Sina Medical News. The views expressed are solely those of the author and do not represent the position of Sina Medical News.